Intravesical Gemcitabine Instillation Followed by Transurethral Resection for the Treatment of Patients With Superficial Bladder Cancer at Low Risk.
Clinical trial NCT00191711 · COMPLETED
Trial details
- NCT number
- NCT00191711
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2004-02-01
- Enrollment
- 43
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.